G

GemVax & KAEL Co Ltd
KOSDAQ:082270

Watchlist Manager
GemVax & KAEL Co Ltd
KOSDAQ:082270
Watchlist
Price: 40 450 KRW -2.76% Market Closed
Market Cap: ₩1.7T

Net Margin

-81.1%
Current
Declining
by 11.4%
vs 3-y average of -69.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-81.1%
=
Net Income
₩-59.7B
/
Revenue
₩73.6B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-81.1%
=
Net Income
₩-59.7B
/
Revenue
₩73.6B

Peer Comparison

Country Company Market Cap Net
Margin
KR
GemVax & KAEL Co Ltd
KOSDAQ:082270
1.8T KRW
Loading...
NL
ASML Holding NV
AEX:ASML
480.5B EUR
Loading...
US
Brooks Automation Inc
LSE:0HQ1
354.8B USD
Loading...
US
Lam Research Corp
NASDAQ:LRCX
301.4B USD
Loading...
US
Applied Materials Inc
NASDAQ:AMAT
266.9B USD
Loading...
US
KLA Corp
NASDAQ:KLAC
213.1B USD
Loading...
JP
Advantest Corp
TSE:6857
19.5T JPY
Loading...
JP
Tokyo Electron Ltd
TSE:8035
18.9T JPY
Loading...
CN
NAURA Technology Group Co Ltd
SZSE:002371
343.6B CNY
Loading...
JP
Disco Corp
TSE:6146
7.3T JPY
Loading...
NL
ASM International NV
AEX:ASM
35.2B EUR
Loading...

Market Distribution

Lower than 92% of companies in Korea
Percentile
8th
Based on 2 632 companies
8th percentile
-81.1%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

GemVax & KAEL Co Ltd
Glance View

Market Cap
1.7T KRW
Industry
Semiconductors

GemVax & KAEL Co., Ltd. engages in the production of chemical filters and gas scrubbers for semiconductors. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2005-06-24. The firm and its subsidiaries are engaged in the three categories of businesses: pollution control business, which manufactures chemical air (CA) filters, gas scrubbers, resins, coating resins and other environmental equipments and systems; anticancer and anti-inflammation business, which engages in development of cancer vaccines for infectious diseases, such as acquired immune deficiency syndrome (AIDS) and anti-inflammations, and IT business which mainly produces liquid crystal display (LCD) modules. The firm distributes its products within domestic market and to overseas markets.

GemVax & KAEL Co Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-81.1%
=
Net Income
₩-59.7B
/
Revenue
₩73.6B
What is GemVax & KAEL Co Ltd's current Net Margin?

The current Net Margin for GemVax & KAEL Co Ltd is -81.1%, which is below its 3-year median of -69.7%.

How has Net Margin changed over time?

Over the last 3 years, GemVax & KAEL Co Ltd’s Net Margin has decreased from -8.2% to -81.1%. During this period, it reached a low of -139.1% on Dec 31, 2024 and a high of -8.2% on Aug 30, 2022.

Back to Top